AMGN: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/2c0e9bab-f77b-41cb-894e-13bd513641d4/","filing_uuid":"2c0e9bab-f77b-41cb-894e-13bd513641d4","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/2c0e9bab-f77b-41cb-894e-13bd513641d4/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Lamoureux","dt_posted":"2026-06-12T17:05:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"3112 Honeysuckle Lane","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Russellville","registrant_state":"AR","registrant_zip":"72801","registrant":{"id":401110643,"url":"https://lda.gov/api/v1/registrants/401110643/","house_registrant_id":null,"name":"MICHAEL J. LAMOUREUX","description":null,"address_1":"3112 Honeysuckle Lane","address_2":null,"address_3":null,"address_4":null,"city":"Russellville","state":"AR","state_display":"Arkansas","zip":"72801","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL J. LAMOUREUX","contact_telephone":"+1 479-886-2277","dt_updated":"2026-05-27T11:25:09.137414-04:00"},"client":{"id":73540,"url":"https://lda.gov/api/v1/clients/73540/","client_id":73540,"name":"AMGEN INC.","general_description":"Biotechnology","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-06-12"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Educating members on issues affecting Amgen and patients","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":153986,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"LAMOUREUX","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}